Sphera Funds Management Ltd. Graphite Bio, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.1 - $13.06 $3.38 Million - $8.66 Million	-663,194 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.41 - $16.71 $1.11 Million - $2.2 Million	131,925 Added 24.83%	663,194 $8.24 Million
Q3 2021 Nov 15, 2021	BUY	$15.81 - $28.39 $8 Million - $14.4 Million	506,312 Added 2028.74%	531,269 $8.71 Million
Q2 2021 Aug 17, 2021	BUY	$18.5 - $30.73 $461,704 - $766,928	24,957 New	24,957 $767,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.